Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dropfree MSICS: Triamcinolone vs Prednisolone in Cataract Surgery
NCT05248139Unknown
- Sponsor
- Visualiza
- Start
- Oct 2022
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
01
Overview
Randomised trial of triamcinolone acetonide in ocular inflammation and macular edema (2 arms), sponsored by Visualiza. Primary endpoints: Intraocular Pressure at 12 weeks and Corrected Distance Visual Acuity at 12 weeks. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
ocular inflammationmacular edema
Beyond the preview
Go deeper on NCT05248139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05248139.